<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538365</url>
  </required_header>
  <id_info>
    <org_study_id>RICBEC1</org_study_id>
    <nct_id>NCT04538365</nct_id>
  </id_info>
  <brief_title>Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60%</brief_title>
  <official_title>Effect on the Reduction of Bacterial Load in Surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60% Used as Reference Disinfectant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Ortopedico y Quirurgico del Pie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Ortopedico y Quirurgico del Pie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study evaluates the effects of bactericidal load reduction after surgical hand&#xD;
      scrub antisepsis using the reference antiseptic product propanol-&#xD;
&#xD;
      1 60% as control versus a surgical hand scrub antisepsis with triclosan 0.5% in order to test&#xD;
      if pass the standard european norm 12791.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators conducted a crossover clinical trial to evaluate the antiseptic&#xD;
      effectiveness of preoperative surgical scrubbing using propan-ol-1 60% by scrub using the&#xD;
      reference antiseptic product propan-ol-1 60% as control versus a surgical hand scrub&#xD;
      antisepsis with trocilosan 0.5% in order to test if pass the standard european norm 12791.&#xD;
      Samples will be taken from the hands of each volunteer after a surgical hands antiseptic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Actual">October 30, 2020</completion_date>
  <primary_completion_date type="Actual">October 20, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover design is used</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The samples will be sent to the laboratory with numbers</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of bacterial load immediately after hand scrub</measure>
    <time_frame>Change from bacterial load at 5 minutes</time_frame>
    <description>Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of bacterial load after 3 hours of hand scrub</measure>
    <time_frame>Change from bacterial load after 3 hours</time_frame>
    <description>Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub after 3 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Antisepsis</condition>
  <arm_group>
    <arm_group_label>Hand antisepsis with propanolol-1 60%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Effectiveness of pre-surgical hand washing in reducing bacterial load using propanolol-1 60% as control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hand antisepsis with triclosan solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Effectiveness of pre-surgical hand washing in reducing bacterial load using triclosan 0.5% solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triclosan 0.5 % Topical Solution</intervention_name>
    <description>Hand antisepsis by scrub Surgical Hand scrubbing using triclosan 0.5% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side</description>
    <arm_group_label>Hand antisepsis with triclosan solution</arm_group_label>
    <other_name>Hand antisepsis with Triclosan 0.5% solution.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propanolol</intervention_name>
    <description>Hand antisepsis by scrub Surgical Hand scrubbing using Propanolol 60% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side</description>
    <arm_group_label>Hand antisepsis with propanolol-1 60%</arm_group_label>
    <other_name>Hand antisepsis with Propanolol 60% solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants without systemic pathologies, with healthy skin of the hands and short&#xD;
             fingernails.&#xD;
&#xD;
          -  They do not use substances with antibacterial action.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taken antibiotics before 10 days of the intervention.&#xD;
&#xD;
          -  Wear any jewellery on the hands&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo B Becerro de Bengoa Vallejo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Complutense de Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Facultad de Enfermeria, Fisioterapia y Podologia</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Ortopedico y Quirurgico del Pie</investigator_affiliation>
    <investigator_full_name>Ricardo Becerro de Bengoa Vallejo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>hand washing</keyword>
  <keyword>presurgical antisepsis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triclosan</mesh_term>
    <mesh_term>Propranolol</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>A number will be assigned to each participant</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

